Frier Levitt is pleased to announce that Life Sciences attorney Guilherme Ferrari has been appointed to two Food and Drug Law Institute (FDLI) committees for 2026.
Guilherme will serve on the Peer Review Committee for FDLI Update Magazine, where he will review manuscripts and provide editorial feedback on scholarly articles submitted for publication by colleagues in the food and drug law space. He has also been selected to join FDLI’s Cannabis-Derived Products Task Force, which tracks and informs emerging legal and regulatory developments impacting the cannabis sector and regulated companies.
These appointments reflect Guilherme’s growing role as a thought leader in the food and drug regulatory space and his ongoing contributions to complex life sciences matters affecting manufacturers, distributors, and other regulated entities.
Senior Associate
